Literature DB >> 11498306

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy.

G Carcelain1, P Debré, B Autran.   

Abstract

Immune reconstitution during antiretroviral therapy has recently been shown to depend upon multiple factors at work in T cell homeostasis, amongst which the reduction of thymus dysfunction and of immune hyperactivation are instrumental. The optimism that has been raised by the restoration of hosts' defenses against opportunistic pathogens is, however, balanced by the poor immunity restored against HIV; thus, innovative immune interventions are required.

Entities:  

Mesh:

Year:  2001        PMID: 11498306     DOI: 10.1016/s0952-7915(00)00245-4

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  16 in total

1.  Study design may explain discrepancies in GB virus C effects on interferon-γ and interleukin-2 production and CD38 expression in T lymphocytes.

Authors:  Nirjal Bhattarai; Jack T Stapleton
Journal:  Mem Inst Oswaldo Cruz       Date:  2012-06       Impact factor: 2.743

2.  Programmed death 1 receptor changes ex vivo in HIV-infected adults following initiation of highly active antiretroviral therapy.

Authors:  Sergei Spitsin; Nancy B Tustin; Eric Riedel; Richard Tustin; Jennifer B Murray; Lauren M Peck; Mohammad Khan; Joseph Quinn; Steven D Douglas
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

Review 3.  Leishmaniasis as a Manifestation of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-Infected Patients: A Literature Review.

Authors:  Roberto Badaró; Larissa O Gonçalves; Luana L Gois; Zuinara Pereira Gusmão Maia; Constance Benson; Maria Fernanda Rios Grassi
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-10-20

4.  Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection.

Authors:  José Peña; Mario Frías; Laura Castro-Orgaz; Rafael González; Felipe García; Teresa Gallart; Jose María Gatell; Montserrat Plana
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

5.  Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells.

Authors:  Xiao-Qing Zhao; Xiao-Li Huang; Phalguni Gupta; Luann Borowski; Zheng Fan; Simon C Watkins; Elaine K Thomas; Charles R Rinaldo
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 6.  Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful.

Authors:  Sjoerd H van der Burg; Joel M Palefsky
Journal:  J Transl Med       Date:  2009-12-18       Impact factor: 5.531

7.  Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis.

Authors:  Shari N Gordon; Richard M Dunham; Jessica C Engram; Jacob Estes; Zichun Wang; Nichole R Klatt; Mirko Paiardini; Ivona V Pandrea; Cristian Apetrei; Donald L Sodora; Ha Youn Lee; Ashley T Haase; Michael D Miller; Amitinder Kaur; Silvija I Staprans; Alan S Perelson; Mark B Feinberg; Guido Silvestri
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

8.  Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso.

Authors:  Fabrice Tiba; Frans Nauwelaers; Siaka Traoré; Boubacar Coulibaly; Thierry Ouedraogo; Adama Compaoré; Hans-Georg Kräusslich; Thomas Böhler
Journal:  Open AIDS J       Date:  2012-02-24

9.  Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.

Authors:  Liviu Feller; Johan Lemmer
Journal:  Infect Agent Cancer       Date:  2008-01-21       Impact factor: 2.965

10.  CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  BMC Infect Dis       Date:  2006-03-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.